Jeffrey G. Lamothe - 08 Aug 2024 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: EVP, COO
Signature: /s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol: APVO
Transactions as of: 08 Aug 2024
Net transactions value: $0
Form type: 4
Filing time: 09 Aug 2024, 16:33:05 UTC
Previous filing: 19 Jul 2024
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+42	+4.9%		894	08 Aug 2024	Direct	F1
transaction	APVO	Common Stock	Options Exercise		+272	+30%		1,166	08 Aug 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-42	-51%	$0.000000	41	08 Aug 2024	Common Stock	42		Direct	F1, F2
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-272	-100%	$0.000000^*	0	08 Aug 2024	Common Stock	272		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023.
F3	On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023.